What COVID-19 means for generics companies

Generics companies have found themselves at the forefront of fighting COVID-19 – but it has required rapid change at all levels of the business. We spoke to Accord’s executive vice president EMENA, Dr James Burt, to get an on-the-ground view of how drug firms like his have had to adapt in these unpredictable times.C